PBIRx®
Intelligent Solutions in Pharmacy Benefits
612 Wheelers Farms Road, Milford, CT 06461
(888) 797-2479
PBIRx has been informed by the FDA Safety Information and Adverse Event Reporting of increased risk of leg and foot amputations with the use of canagliflozin brands (Invokana, Invokamet, Invokamet XR). The FDA will be requiring new warnings including Boxed Warning to be added to the canagliflozin drug labels to describe the risk.
The FDA has the following recommendation:
"Patients taking canagliflozin should notify your health care professionals right away if you develop new pain or tenderness, sores or ulcers, or infections in your legs or feet. Talk to your health care professional if you have questions or concerns. Do not stop taking your diabetes medicine without first talking to your health care professional."
Please follow the link to the FDA article:
PBIRx has been exclusively providing intelligent solutions to clients in the management of pharmacy benefit costs since 1993. With a staff that includes IT personnel, actuaries, financial analysts, clinical pharmacists, attorneys, HIPAA Compliance Officers and many more experts, PBIRx’s mission is to create optimal health care outcomes while minimizing overall health care costs. For more information, please visit www.pbirx.com or call (888) 797-2479.
No comments:
Post a Comment